(3)Commission Implementing Regulation (EU) 2023/114note extended the approval period of the active substances buprofezin, mecoprop-P and pyraclostrobin until 31 January 2024, of the active substances fluazinam, flutolanil and mepiquat until 29 February 2024, of the active substance benzovindiflupyr until 2 March 2024 and of the active substances cyflufenamid, lambda-cyhalothrin, metsulfuron-methyl and phosphane until 31 March 2024.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.